Lisata Therapeutics, Inc.
LSTA
$1.09
-$0.04-3.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.62M | -16.35M | -16.59M | -18.24M | -18.92M |
| Total Depreciation and Amortization | 64.00K | 105.00K | 146.00K | 172.00K | 170.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.65M | 1.65M | 1.78M | 1.48M | 1.53M |
| Change in Net Operating Assets | 586.00K | 963.00K | -1.29M | -640.00K | 819.00K |
| Cash from Operations | -12.32M | -13.63M | -15.95M | -17.23M | -16.40M |
| Capital Expenditure | 0.00 | 0.00 | -28.00K | -28.00K | -28.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.15M | 5.66M | 15.11M | 16.50M | 5.05M |
| Cash from Investing | 5.15M | 5.66M | 15.09M | 16.48M | 5.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 927.00K | 972.00K | 852.00K | 683.00K | 330.00K |
| Repurchase of Common Stock | -159.00K | -169.00K | -253.00K | -385.00K | -385.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 768.00K | 803.00K | 599.00K | 298.00K | -55.00K |
| Foreign Exchange rate Adjustments | 13.00K | 15.00K | 11.00K | -56.00K | -19.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.39M | -7.16M | -253.00K | -511.00K | -11.46M |